GB-Virus Typ C (GBV-C)
- Book ID
- 105704999
- Publisher
- Springer-Verlag
- Year
- 1998
- Weight
- 345 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0007-5914
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The development of new antiretroviral agents may improve survival of HIV-infected individuals, and therefore chronic viral hepatitis may become more relevant in these patients. The presence of GBV-C/HGV and hepatitis C virus (HCV) RNA were investigated by reverse transcriptasenested polymerase chain
Multiple genotypes of GB virus C (GBV-C)-a non-pathogenic flavivirus-have been identified to date, although they are not uniformly distributed worldwide. It has also been suggested that GBV-C genotype may play a role in modulating HIV disease; however, the prevalence and genotype distribution of GBV
Among risk groups for GB virus C (GBV-C)/HGV infection, patients with haematological diseases are particularly exposed due to the combination of transfusional support and immunodeficiency status. To examine any association between GBV-C/HGV positivity and different malignancy potential of hematologi
We compared characteristics of patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA to those of patients with GBV-C/HGV E2-antibody. GBV-C/HGV RNA and GBV-C/HGV antibody were assayed in 83 persons with hemophilia using a reverse transcription-polymerase chain reaction and an enzyme-linked immu
## Abstract Several recent studies have indicated that patients infected with human immunodeficiency virus (HIV) exhibit a beneficial effect of coβinfection with GB virus C (GBVβC). The benefit is demonstrated by slower progression to acquired immunodeficiency syndrome (AIDS) and prolonged survival